Bone Diseases
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesestrogens, conjugated
StrykerVitoss
A&D MedicalVitoss
Clinical Trials (3)
Total enrollment: 163 patients across 3 trials
Postmenopausal Estrogen/Progestin Interventions (PEPI)
Start: Sep 1987Est. completion: Oct 2000
Phase 3Completed
Evaluation of Vitoss With and Without BMA for Benign Cavitary Lesions
Start: Jan 2014Est. completion: Dec 2014100 patients
N/AUnknown
Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions
Start: Dec 2004Est. completion: Dec 201163 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.